FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Cellular, Tissue and Gene Therapies Advisory Committee
(Formerly Biological Response Modifiers Advisory Committee)

horizontal rule

July 13, 2001 Meeting

Date and Time

The meeting will be held on July 13, 2001, 8:30 a.m. to 4:00 p.m.

Location

Holiday Inn, Versailles Ballrooms I and II, 8120 Wisconsin Avenue, Bethesda, MD, 301-652-2000

Contact Person

Gail Dapolito or Rosanna L. Harvey, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138, (301-443-0572 in the Washington, DC area), code 12389. Please call the Information Line for up-to-date information on this meeting.

Agenda

On July 13, 2001, the committee will meet to 1)to discuss responses to the March 6, 2000 FDA Gene Therapy Letter related to adenovirus vector titer measurements and replication competent adenovirus levels in gene transfer products.

Oral Presentations

Between approximately 11:00 a.m. and 12:00 noon oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before July 6, 2001.

 

 
horizontal rule